-
中文名稱：pdeH兔多克隆抗體, Biotin偶聯
-
貨號：CSB-PA336327LD01ENV
-
規格：￥880
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Escherichia coli (strain K12) pdeH Polyclonal antibody
-
Uniprot No.：
-
基因名：pdeH
-
別名：pdeH antibody; yhjH antibody; b3525 antibody; JW3493 antibody; Cyclic di-GMP phosphodiesterase PdeH antibody; EC 3.1.4.52 antibody
-
宿主：Rabbit
-
反應種屬：Escherichia coli
-
免疫原：Recombinant Escherichia coli Cyclic di-GMP phosphodiesterase PdeH protein (1-255AA)
-
免疫原種屬：Escherichia coli (strain K12)
-
標記方式：Biotin
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
產品提供形式：Liquid
-
應用范圍：ELISA
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Involved in the control of the switch from cell motility to adhesion via regulation of cellular levels of cyclic-di-GMP (c-di-GMP). Part of a signaling cascade that regulates curli biosynthesis. The cascade is composed of two c-di-GMP control modules, in which c-di-GMP controlled by the DgcE/PdeH pair (module I) regulates the activity of the DgcM/PdeR pair (module II), which in turn regulates activity of the transcription factor MlrA and expression of the master biofilm regulator csgD. Effect on flagella is controlled via the c-di-GMP-binding flagellar brake protein YcgR.
-
數據庫鏈接：
KEGG: ecj:JW3493
STRING: 316385.ECDH10B_3702
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
